2021 SPEAKERS INCLUDE
Connect with the world’s leaders from wherever you are.
Join us in 2021 for our best line up yet.
Sameh Abdou, Market Access & Strategic Alliance Manager Middle East & Africa, Abbott L.A
Mostafa Alabed, Health Economics Analyst, Evaluation and Impact Measurement Unit, Ministry Of Health - Kingdom Of Saudi Arabia
David Alderson, Director, Cogentia Healthcare Consulting
Ines Alves, President, ANDO Portugal
Diego Ardigo, Head of R&D, Global Rare Diseases, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, Riziv-Inami
Nadeem Ashraf, Head of CardioMetabolism for Medical Affairs, UK & Ireland, Boehringer Ingelheim
Kagan Atikeler, Market Access Manager, Sanofi-Aventis Turkey
Indranil Bagchi, Senior Vice President And Head Of Global Value And Access, Novartis
Alex Bastian, Vice President, Value And Market Access, Galapagos NV
Antje Behring, Head of Pharmaceuticals Department, G-BA
Tomer Ben Zaken, Pricing And Alliance Manager, Takeda
Karsten Berndt, International HTA Lead, Myriad Genetics GmbH
Jennifer Cain Birkmose, Vice President, Global Head Of Patient Access And Community Engagement, Swedish Orphan Biovitrum
Jesper Bjerggren, Senior Market Access Manager, Teva Denmark
Maria Alejandra Blanc, Director - Regulatory Affairs – Region South America, AbbVie
Nadia Bodkin, Founding member, Rare Advocacy Movement
Axel Boehnke, Director Market Access EU North, PTC Therapeutics
Luc Boileau, Chairman And Chief Executive Officer, INESSS
Thomas Bols, Head of Government Affairs and Public Policy, EMEA & APAC, PTC Therapeutics
Luciene Fontes Schluckebier Bonan, Innovation and HTA General Coordinator, Ministry of Health - Brazil
Meindert Boysen, Deputy Chief Executive and Director of the Centre for Health Technology Evaluation, National Institute for Health and Care Excellence
Hassan Bruneo, Head of Market Access, Pricing & Policy CEMEA, Alnylam Switzerland Gmbh
Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)
Sandro Cesaro-Tadic, Head Pricing I8 And Product Pricing Strategies, Roche
Anjan Chatterjee, Senior Vice President - Global Head, Medical Affairs, Insmed Incorporated
Helene Chevrou-Severac, HEOR Director, alexion
Mouna Jameleddine Chtioui, Director of the Health Technology Assessment Department, INEAS - TUNISIA
Ali Ciger, Commercial Director, Pain, Pfizer
Mike Crosher, Managing Director, Chugai Pharma UK
Omar Dabbous, Vice President, Global Heor and Rwe, AveXis Inc
Paolo D'Agostino, EU Market Access Lead, Seqirus
Aletta de Beer, Product Owner Intensive Care, Pacmed
Charles-Etienne de Cidrac, Director Of Health Insurance, AXA
Erwin De Cock, Executive Director, Clinical Engagement, Syneos Health
Michele de Guise, Scientific Vice-President, INESSS
Kate Dion, Value Communications Lead, 3D Communications
Valentin Dodonov, Head of Market Access, BIOCAD
Filippo Drago, Full Professor of Clinical Pharmacology, University of Catania
Gilles Ducorroy, Head of RWE Services, Novartis
Dominik Dziurda, Head Of Health Services Division, AOTMiT
Jenny Ebert, National Account Director, Ascendis Pharma
Mercedes Echauri, Head of Pricing, Value and Access , EUCAN, Takeda
Jaime Espin, Professor, Andalusian School Of Public Health
Gina Ewy, Head Of Global Market Access, Hansa Biopharma
Valerie Faillat, Head of Sanofi Espoir Foundation, Sanofi
Douglas Foerster, Head Market Access, Santhera Pharmaceuticals
Isabelle Ganache, Director of Bureau for Methodologies and Ethics, INESSS
Benjamin Gannon, Vice President International Access, Policy And Advocacy, Myriad genetics
Josie Godfrey, Director, JG Zebra Consulting
Wim Goettsch, Special Hta-Advisor, Zorginstituut
Alfredo Gracia, Field Market Access Manager Spain, Baxter
Sylvie Greneche, Global Head of Market Access, General Medicines, Sanofi
Laura Guarga, Consultant of Pharmacoeconomic Department, CatSalut
Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical
Bernard Hamelin, Global Head Of Medical Evidence Generation, Sanofi
Zahraa Hassan, Pharmacoeconomics Unit, Egyptian drug authority
Birgit Holz, Global Head of Contracting Innovation, sanofi
Dawn Torrence Ireland, President And Founder, C.H.E.R.U.B.S.
Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen
Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey
Elizabeth Johnson, Lead Biologics Coordinator, Allergy Partners, P.A.
Navin Joshi, Global Head of Pricing and Access Capabilities, GlaxoSmithKline
Marcela Junqueira, Oncology Market Access Director - Latin America, Janssen Pharmaceutical
Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical
Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, Roche
Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator Applications
Jolanda Koenders, Head Of Patient Value And Access, Takeda
Adam Kundzewicz, Global Head of Strategic Market Access Initiatives, Boehringer Ingelheim
Jost Leemhuis, Head Of Safety Science, Roche
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Gavin Lewis, Vice President For Value, Access And Policy, Amgen
Nanxin (Nick) Li, Senior Director and Head, Health Economics and Outcomes Research (HEOR), uniQure
Edmund Lim, Executive Director, We CARE Journey
Catarina Lopes Pereira, Global Market Access Manager, Medac
Elena Lungu, Manager Of Policy Development, Government of Canada
Alastair Macdonald, Senior Vice President Of Real World And Late Phase, Syneos Health
Mark Macgregor, Medical Director and Chair, New Drugs Committee, Scottish Medicines Consortium, Golden Jubilee National Hospital
Andrea Mantovani, Former Market Access Executive, Independent
Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita
Dan McLean, Senior Manager, Pan-Canadian Pharmaceutical Alliance Office
Erin Mistry, SVP, Head of Payer Strategy, Gov’t Affairs and Trade Relations, CorMedix Inc
Vladimir Mladov, HTA Manager, BIOCAD
Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine
Thomas Mueller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany
Michael Muller, Head Of Market Access, Western Europe, Sun Pharma
Diane Munch, Head of Global Pricing, Patient & Health Impact, Pfizer
Nuriya Musina, Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme, Ministry of Health Russian Federation
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical
Mark Nuijten, Chief Executive Officer, A2M - Minerva
Oleksandra Oleshchuk, Head of Committee, EML Committee of Ukraine
Pier Paolo Olimpieri, Data Analyst Coordinator, Monitoring Registries Office, AIFA
Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma
Amer Omar, Head of Access & Reimbursement EMEA Neuroscience - Rare & Genetic Disease, Lupin
Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre
Mario Ouwens, Group Director Medical & Payer Evidence Statistics, Astra Zeneca
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, DAK-Gesundheit
Anusha Patel, High Costs Drugs Pharmacist and Regional Homecare Lead Pharmacist, Kettering General Hospital
Julien Patris, Country Manager Belgium & Luxembourg // Director Market Access & Policy CEMEA, Alnylam
Diogo Teixeira Pereira, Policy Analyst - Office for International Relations and Development, Infarmed
Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Oresta Piniazhko, Director, Hta Department, Ministry of Health of Ukraine
Lara Pippo, Head Of Market Access, CSL Behring
Ana Plata, Global Head of Pricing, UCB
Adam Plich, Managing Director, Plich Advisory
Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP
Angelina Irizari Policarpio, Head of HEOR and RWE Field Communications Team, Eisai
Diann Potestio, SVP Market Access, Reimbursement & Channel Strategy, Acadia Pharmaceuticals Inc.
Marco Rauland, Vice President Global Market Access & Pricing Strategic Planning, Merck Group
Laurene Redding, Former AVP Pharmaceutical Benefits and Innovation, Sun Life Financial
Vijay Reddy, Global Market Access and Outcomes Research Leader - CCS Portfolio, GE Healthcare
Isabell Remus, Head Biopharmaceuticals Europe, Sandoz
Trevor Richter, Director, Pharmaceutical Reviews, CADTH
Kevin Rieger, Head Of Public And Governmental Affairs Dach, Ipsen Pharma Gmbh
Shirin Rizzardo, Director of Specialty Medicines, Ministry of Health, British Columbia
Juan Roman, Vice President, Global Market Access, HEOR and Pricing, Krystal Biotech
Igor Rudychev, Vice President, Enterprise Analytics, Horizon Therapeutics
Asmaa Saad, Head of the Pharmacoeconomics unit, Egyptian drug authority
Ryan Saadi, CEO, Tevogen Bio
Marcelo Sal, Head of Market Access and Pricing, South Cone of South America, PTC Therapeutics
Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline
Marie Theres Schmidt, Director Market Access And Government Affairs, Edwards Lifesciences
Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda
Michael Schroter, Partner, VIOPAS Partners
Martin Schuchardt, Global Market Access Lead, Almirall
Ayman Semaan, Head of Market Access, Algorithm
Maja Sercic, Policy & Science Manager, Medicines for Europe
Alexis Serlin, Head, Asia Cluster, Novartis
Jonas Sertorio, Innovation and HTA Consultant, Ministry of Health - Brazil
Rita Shorjian, Business Unit Director – Gulf Countries, Specialty, HCV & Oncology, AbbVie
Tamir Singer, Head of Commercial Development, NHS England
Matt Slabbert, Global Head, Value & Access Policy, Bayer Pharmaceuticals
Valeriia Sokolova, Health Economics Manager, BIOCAD
Daniel Sperber, Senior Economist, Pan-Canadian Pharmaceutical Alliance Office
Giovanni Tafuri, Director, International Pricing & Reimbursement and Policy Strategy, Apellis Pharmaceuticals
Bertrand Tardivel, General Manager, Frehel/ContrAST
Samuel Taylor, Emerging Markets Strategic Pricing Lead, Pfizer
Chris Teale, Vice President Market Access, Ipsos MORI UK Ltd
Daria Tolkacheva, Head of Health Economics, BIOCAD
Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence
Inneke Van De Vijver, Strategic Advisor - Reimbursement Pharmaceuticals, R.I.Z.I.V. I.N.A.M.I. National Health Insurance Agency
Erik Van Den Berg, Chief Executive Officer, A.M. Pharma
Bart Van Den Daele, Head Of External Affairs - Director Market Access, Gilead Sciences
Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health
Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia
David Watson, Executive Director, Economic, Health and Commercial Policy, ABPI
Anne Willemsen, Senior Project Manager, Joint Production Co-Lead Partner – Pharmaceuticals, Zorginstituut Nederland / EUnetHTA
Natasa Zibelnik, Global Head Of Market Access, EUSA Pharma
Fabrizio Zucca, Director Market Access Dach, Intercept Pharmaceuticals Inc
Get Involved With Evidence, Pricing and Access Congress
To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
